SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as investors react to the company's recent leadership transition, the appointment of former Pfizer CMO Dr. Freda Lewis-Hall to its board, and anticipation surrounding upcoming Phase 2 data for its GAD program. The community remains polarized, with some highlighting the company's robust IP portfolio and institutional accumulation, while others express concerns over the stock's historical volatility and ongoing cash burn.

Beamable Network is a decentralized compute infrastructure designed to power real games and digital experiences. Built by the team behind Beamable Inc.—a backend platform already serving over 95 live games—the network transforms compute into an open, tokenized marketplace. By combining distributed node operators, verifiable workloads, and blockchain incentives, Beamable Network provides scalable, cost-efficient infrastructure for any compute applications without dependence on centralized cloud providers.

Beamable Network Token

Beamable Network Token is experiencing heightened community interest driven by rapid price volatility and significant order book activity. Traders are actively tracking potential breakout patterns while debating the sustainability of the current momentum amid broader market speculation.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending as investors monitor significant short interest and volatility following recent ASH presentations and potential M&A speculation. The community is actively discussing the company's transition into a profitable commercial entity while awaiting further catalysts like potential pipeline updates or partnership news.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing heightened engagement as community members discuss a potential breakout fueled by renewed interest in the ApeChain ecosystem and NFT sector sentiment. Traders are closely watching key technical resistance levels and volume surges as the asset draws attention for its volatility and connection to broader crypto market momentum.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is generating significant community conversation as traders weigh its consolidation patterns against historical volatility and speculation surrounding potential integration with major social platforms. While some investors remain cautious due to sluggish price action compared to other assets, many are actively debating if it is currently positioned for a breakout or a further downturn.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea is trending due to significant community excitement surrounding its role in a SWIFT pilot program, with investors speculating it could become a major institutional player within the Ethereum ecosystem. While supporters emphasize its technical partnerships and potential for mass adoption, community discourse remains polarized, with active discussions focusing on token unlock schedules, price volatility, and comparisons to legacy blockchain projects.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors debate the impact of the company's recent massive acquisition of TopBuild, with the community split between those betting on Brad Jacobs' track record for long-term growth and those expressing concern over share dilution and high valuation metrics. Traders are actively discussing support levels, potential further acquisition news, and the stock's sensitivity to broader sector headwinds and macroeconomic shifts.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is facing immense downward pressure as the semiconductor sector continues a historic, parabolic rally that has pushed major chip stocks to record-breaking streaks. Investors are actively debating whether this movement represents an unsustainable bubble or a new super-cycle, with many using the fund as a high-risk hedge against further sector expansion.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is seeing heavy market engagement as investors weigh strong Q2 earnings, which featured double-digit volume growth in key assets like Repatha and Evenity, against concerns over pricing pressures and patent cliffs. The community is actively discussing Amgens competitive positioning in the high-stakes obesity pipeline alongside speculation regarding future M&A potential and the company's long-term manufacturing expansion strategy.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Gold and Silver Corporation

Americas Gold and Silver Corporation is trending as investors monitor the company's dual exposure to surging silver prices and critical antimony demand. Community discussion centers on potential upside from production expansion at the Crescent mine and the strategic importance of domestic antimony supply amid supply chain concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should State Street SPDR S&P 600 Small Cap Value ETF (SLYV) Be on Your Investing Radar?

Should SPDR S&P 600 Small Cap Value ETF (SLYV) Be on Your Investing Radar?

Retail sentiment for Carvana (CVNA) remained 'bearish'&nbsp;late Wednesday despite the online used-car retailer's strong earnings report, with some Stocktwits users voicing skepticism, suggesting the results seem almost too good to be true and may warrant a deeper investigation.Carvana was among the top 10 trending tickers, with message volume around the stock surging over 375% in the last 24 hours, according to Stocktwits data.<figure class="image"><img style="aspect-ratio:1262/154;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_31_at_7_47_29_AM_png_3367633f96.webp" alt="Screenshot 2025-07-31 at 7.47.29 AM.png" width="1262" height="154"><figcaption>CVNA sentiment and message volume as of July 30 | Source: Stocktwits</figcaption></figure>The company said revenue in its second quarter rose 42% to $4.84 billion, and it sold a record 143,280 car units in the period. Analysts surveyed by FactSet were expecting revenue of $4.58 billion.Adjusted profit rose to $1.28 per share from $0.14 in the year-ago quarter. That, too, easily beat expectations of $1.17.Carvana has drawn increased investor interest in recent months as the used-car market heats up amid Trump-era tariffs. With buyers looking to hedge against potential price hikes, demand is shifting toward more affordable options, particularly used vehicles.However, a 64% stock gain year-to-date, and about 40% year-on-year sales growth in the preceding Q1 2025 and Q4 2024 are making&nbsp;some investors jittery."There's no way those books are legit. People are calling them out left and right," a user said. "They're worth more than some of the major car brands. It's impossible."<stembedurl>https://stocktwits.com/rainmaker1967/message/623116855</stembedurl>Carvana’s market capitalization stands at over $45 billion as of the last close. That’s more than that of Ford, Stellantis or Rivian.&nbsp;It is not the first time the company&nbsp;has stirred up such concerns. A Hindenberg report in January&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carvana-stock-volatile-after-hindenburg-short-report-that-alleges-accounting-manipulation/cW6v7r0RlB">accused</a> the e-commerce car company of accounting manipulation, including handing out millions of dollars in suspicious loan sales to undisclosed customers.Carvana said it has been subpoenaed by the Securities and Exchange Commission for information related to the Hindenburg report.Another Stocktwits user remarked in a lighter vein: "$CVNA the netflix special on this scam in 5 years will be a fun watch."&nbsp;<stembedurl>https://stocktwits.com/earlyretirmnt/message/623109216</stembedurl>Yet another said, “A collapse is coming. Be very diligent!”<stembedurl>https://stocktwits.com/gr8whitenorth/message/623138152</stembedurl>Notwithstanding these claims, <a href="https://stocktwits.com/symbol/CVNA">Carvana shares</a> rose 15% in extended trading, following the results."Looking toward the third quarter, as long as the environment remains stable, Carvana expects a sequential increase in retail units sold and Adjusted EBITDA of $2.0 to $2.2 billion for the full year 2025, an increase from $1.38 billion last year," the company statement said.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In an aerial view, a sign is posted on the exterior of a Carvana car vending machine on July 19, 2023 in Daly City, California.

SLYV
SPDR S&P 600 Small Cap Value ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SLYV News

SLYVSPDR S&P 600 Small Cap Value ETF